- STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
- STAAR Surgical Reports First Quarter 2024 Results
- STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
- STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
- STAAR Surgical to Report First Quarter Results on May 7, 2024
More ▼
Key statistics
On Tuesday, STAAR Surgical Co (SR3:STU) closed at 44.03, -15.52% below its 52-week high of 52.12, set on Jul 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 44.03 |
---|---|
High | 44.03 |
Low | 44.03 |
Bid | 40.72 |
Offer | 42.18 |
Previous close | 44.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.13m |
Free float | 48.88m |
P/E (TTM) | 143.92 |
Market cap | 2.19bn USD |
EPS (TTM) | 0.3093 USD |
Data delayed at least 15 minutes, as of Jul 02 2024.
More ▼